Global Amygdalin market was valued at USD 22 million in 2023 and is projected to reach USD 29 million by 2030, at a CAGR of 4.4% during the forecast period.
The USA market for Global Amygdalin market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Amygdalin market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Amygdalin market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Amygdalin market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Amygdalin market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Amygdalin, challenges faced by the industry, and potential opportunities for market players.
The global Amygdalin market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Amygdalin market presents opportunities for various stakeholders, including Food Industry, Pharmaceuticals Industry. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Amygdalin market. Additionally, the growing consumer demand present avenues for market expansion.
Chemical is an important driver of this industry. Emerging economies, particularly in Asia and Latin America, are experiencing rapid industrialization, urbanization, and population growth. This drives the demand for bulk chemicals across various sectors, including construction, automotive, electronics, agriculture, and consumer goods. The rising middle class in these regions is also contributing to increased consumption of chemical products.
Key Features:
The research report on the Amygdalin market includes several key features to provide comprehensive insights and facilitate decision‑making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Amygdalin market.
Market Overview: The report provides a comprehensive overview of the Amygdalin market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 0.99, 0.98), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Amygdalin market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Amygdalin market’s trajectory.
Competitive Landscape: The report provides an in‑depth analysis of the competitive landscape within the Amygdalin market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segments the Amygdalin market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Amygdalin market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Amygdalin market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Amygdalin, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report concludes with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations are based on the research findings and address key challenges and opportunities within the Amygdalin market.
Supporting Data and Appendices: The report includes supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market segment by Type
- 0.99
- 0.98
- Other
Market segment by Application
- Food Industry
- Pharmaceuticals Industry
- Other
Global Amygdalin Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Salus Nutra
- Freshine Chem
- Xi’an Arisun ChemPharm
- Shaanxi Guanjie Technology
- Aktin Chemicals
- Yangling Ciyuan Biotech
- Nanjing Jingzhu Bio-Tech
- Global Amygdalin Corp
- Prime Chemical Ltd.
- EcoBio Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Amygdalin, market overview.
Chapter 2: Global Amygdalin market size in revenue and volume.
Chapter 3: Detailed analysis of Amygdalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amygdalin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Amygdalin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Get a Detailed Research Report on Amygdalin Market
Amygdalin Market – View in Detailed Research Report
🔟 1. Salus Nutra
Headquarters: San Francisco, California, USA
Key Offering: 0.99 Amygdalin Extract, 0.98 Amygdalin Extract
Salus Nutra is a leading supplier of high‑purity Amygdalin for food and pharmaceutical applications. The company’s product portfolio caters to both domestic and international markets, with a focus on nutraceuticals and natural health products.
Sustainability Initiatives:
- Adopting green extraction processes to reduce solvent usage
- Investing in renewable energy for manufacturing facilities
- Partnering with NGOs for sustainable sourcing of almonds and bitter apricots
9️⃣ 2. Freshine Chem
Headquarters: Shanghai, China
Key Offering: Bulk Amygdalin, 0.99 Amygdalin Concentrate
Freshine Chem specializes in large‑scale production of Amygdalin, supplying the pharmaceutical and food industries across Asia. The company has recently expanded its production capacity to meet rising demand.
Sustainability Initiatives:
- Implementing water recycling systems in production lines
- Reducing carbon footprint through energy‑efficient equipment
- Engaging in community outreach to promote healthy eating habits
8️⃣ 3. Xi’an Arisun ChemPharm
Headquarters: Xi’an, China
Key Offering: Pharmaceutical‑grade Amygdalin, 0.98 Amygdalin
Xi’an Arisun ChemPharm focuses on the development of Amygdalin for therapeutic applications, particularly in oncology and anti‑inflammatory drug development.
Sustainability Initiatives:
- Collaborating with academic institutions for green chemistry research
- Using biodegradable packaging for product distribution
- Supporting local farmers with sustainable cultivation practices
7️⃣ 4. Shaanxi Guanjie Technology
Headquarters: Xi’an, China
Key Offering: Food‑grade Amygdalin, Bulk Production
Shaanxi Guanjie Technology is a key player in supplying Amygdalin for food fortification and functional food ingredients.
Sustainability Initiatives:
- Implementing zero‑waste production processes
- Investing in solar power for manufacturing plants
- Promoting circular economy practices within the supply chain
6️⃣ 5. Aktin Chemicals
Headquarters: Munich, Germany
Key Offering: Specialty Amygdalin, 0.99 Amygdalin
Aktin Chemicals offers high‑purity Amygdalin for pharmaceutical research and development, with a strong focus on regulatory compliance and quality assurance.
Sustainability Initiatives:
- Adhering to EU Green Chemistry guidelines
- Reducing packaging waste through recyclable materials
- Engaging in cross‑border collaborations for sustainable sourcing
5️⃣ 6. Yangling Ciyuan Biotech
Headquarters: Yangling, China
Key Offering: Biotech‑grade Amygdalin, 0.98 Amygdalin
Yangling Ciyuan Biotech focuses on the biotechnological synthesis of Amygdalin, providing innovative solutions for drug delivery systems.
Sustainability Initiatives:
- Developing bio‑based synthesis routes to reduce chemical waste
- Investing in green energy for bioprocessing units
- Collaborating with universities for sustainable research
4️⃣ 7. Nanjing Jingzhu Bio-Tech
Headquarters: Nanjing, China
Key Offering: Bio‑derived Amygdalin, 0.99 Amygdalin
Nanjing Jingzhu Bio-Tech specializes in the extraction of Amygdalin from natural sources, catering to both the nutraceutical and pharmaceutical markets.
Sustainability Initiatives:
- Implementing eco‑friendly extraction technologies
- Supporting local farmers with sustainable cultivation methods
- Reducing carbon emissions through optimized logistics
3️⃣ 8. Global Amygdalin Corp
Headquarters: Toronto, Canada
Key Offering: Global Distribution of Amygdalin, 0.98 Amygdalin
Global Amygdalin Corp operates a worldwide distribution network, ensuring consistent supply to food and pharmaceutical clients across continents.
Sustainability Initiatives:
- Using electric vehicles for last‑mile delivery
- Optimizing supply chain to reduce emissions
- Partnering with NGOs for sustainable sourcing
2️⃣ 9. Prime Chemical Ltd.
Headquarters: Mumbai, India
Key Offering: Bulk Amygdalin, 0.99 Amygdalin
Prime Chemical Ltd. is a major supplier of Amygdalin in the Indian market, focusing on affordable pricing and high quality for domestic consumers.
Sustainability Initiatives:
- Implementing energy‑efficient processes
- Using renewable energy sources for production
- Supporting local communities through health initiatives
1️⃣ 10. EcoBio Pharma
Headquarters: London, United Kingdom
Key Offering: Pharmaceutical‑grade Amygdalin, 0.98 Amygdalin
EcoBio Pharma specializes in developing Amygdalin‑based therapeutics, with a strong focus on clinical trials and regulatory approvals.
Sustainability Initiatives:
- Adhering to UK Green Deal standards
- Using biodegradable packaging for all products
- Investing in research for sustainable extraction methods
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/263350/global-amygdalin-forecast-market-2024-2030-0
Get Full Report Here: https://www.24chemicalresearch.com/reports/263350/global-amygdalin-forecast-market-2024-2030-0
🌍 Outlook: The Future of Amygdalin Market
The Amygdalin market is set to evolve with increasing focus on sustainable sourcing, regulatory compliance, and innovation in extraction technologies. While the global market size is modest, the compound annual growth rate of 4.4% indicates steady expansion driven by health‑conscious consumers and the pharmaceutical sector’s demand for natural compounds.
📈 Key Trends Shaping the Market:
- Shift towards greener extraction methods and renewable energy usage
- Growing demand for Amygdalin in functional foods and nutraceuticals
- Expansion of regulatory frameworks to ensure product safety and efficacy
- Increased collaborations between academia, industry, and government for research and development
These dynamics will open new opportunities for manufacturers, investors, and policymakers to capitalize on the expanding Amygdalin market.
- Top 10 Companies in the Germany Plastics for Barrier Packaging Market (2026): Market Leaders Powering Global Packaging - June 2, 2026
- Top 10 Companies in the Polybutylene Terephthalate Alloy (PBT Alloy) Market (2026): Market Leaders Powering Global Industry - June 2, 2026
- Top 10 Companies in the India Abrasives Market (2026): Market Leaders Driving Industrial Precision - June 2, 2026
